|
 |
| home > epc > summer 2004 > in the european court opens a small window of opportunity for pharmaceutical companies to restrict parallel imports of medicines |
|
|
 PUBLICATIONS |
Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!
Already registered? Please sign in.
Alternatively, please use our pay-per-view service. |
|
|
 |
Industry Events |
 |
BIO-Europe Spring 2009
16-18 March 2009, Milano Convention Centre, Milan, Italy
The BIO-Europe Spring® event brings together international decision-makers from all sectors of the biotechnology industry, and features the successful combination of one-to-one meetings, company presentations, panel discussions and a lively exhibition. Positioned as the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, the BIO-Europe Spring event continues the tradition of providing life science companies with high calibre partnering opportunities. The event enables biotechnology companies to identify, meet and network with companies across the biotechnology value- chain from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
Novozymes Biopolymer Wins Gold Innovation Award for
Novozymes Biopolymer announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA) HyaCare®. The CPhI Innovation Award is established as the showcase for exceptional work in developing research and technology, setting the standards for the pharmaceutical manufacturing industry. The judging panel took into account a number of factors including effective development of the technology and its key benefits to the pharmaceutical industry.
More info >> |
|
|
